These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 27251204)

  • 1. Trends and determinants of IUD use in the USA, 2002-2012.
    Mosher WD; Moreau C; Lantos H
    Hum Reprod; 2016 Aug; 31(8):1696-702. PubMed ID: 27251204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
    Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S
    Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of users of intrauterine devices and other reversible contraceptive methods in the United States.
    Xu X; Macaluso M; Frost J; Anderson JE; Curtis K; Grosse SD
    Fertil Steril; 2011 Nov; 96(5):1138-44. PubMed ID: 21917255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IUD use in France: women's and physician's perspectives.
    Moreau C; Bohet A; Hassoun D; Ringa V; Bajos N;
    Contraception; 2014 Jan; 89(1):9-16. PubMed ID: 24239330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimated disability-adjusted life years averted by long-term provision of long acting contraceptive methods in a Brazilian clinic.
    Bahamondes L; Bottura BF; Bahamondes MV; Gonçalves MP; Correia VM; Espejo-Arce X; Sousa MH; Monteiro I; Fernandes A
    Hum Reprod; 2014 Oct; 29(10):2163-70. PubMed ID: 25085802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends and determinants of use of long-acting reversible contraception use among young women in France: results from three national surveys conducted between 2000 and 2010.
    Moreau C; Bohet A; Hassoun D; Teboul M; Bajos N;
    Fertil Steril; 2013 Aug; 100(2):451-8. PubMed ID: 23663994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrauterine Contraception Continuation in Adolescents and Young Women: A Systematic Review.
    Usinger KM; Gola SB; Weis M; Smaldone A
    J Pediatr Adolesc Gynecol; 2016 Dec; 29(6):659-667. PubMed ID: 27386754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expanding Access to the Intrauterine Device in Public Health Facilities in Ethiopia: A Mixed-Methods Study.
    Tilahun Y; Mehta S; Zerihun H; Lew C; Brooks MI; Nigatu T; Hagos KL; Asnake M; Tasissa A; Ali S; Desalegn K; Adane G
    Glob Health Sci Pract; 2016 Mar; 4(1):16-28. PubMed ID: 27016541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early provision of intrauterine contraception as part of abortion care-5-year results of a randomised controlled trial.
    Pohjoranta E; Suhonen S; Gissler M; Ikonen P; Mentula M; Heikinheimo O
    Hum Reprod; 2020 Apr; 35(4):796-804. PubMed ID: 32266392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of the intrauterine device among adolescent and young adult women in the United States from 2002 to 2010.
    Whitaker AK; Sisco KM; Tomlinson AN; Dude AM; Martins SL
    J Adolesc Health; 2013 Sep; 53(3):401-6. PubMed ID: 23763968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Success Providing Postpartum Intrauterine Devices in Private-Sector Health Care Facilities in Nigeria: Factors Associated With Uptake.
    Eluwa GIe; Atamewalen R; Odogwu K; Ahonsi B
    Glob Health Sci Pract; 2016 Jun; 4(2):276-83. PubMed ID: 27353620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects on Navajo birthrate from loss of the intrauterine device.
    Williams RL
    J Health Care Poor Underserved; 1994; 5(1):47-54. PubMed ID: 8180289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The end of IUD marketing in the United States: what does it mean for American women?].
    Forrest JD
    Contracept Fertil Sex (Paris); 1987 Mar; 15(3):291-300. PubMed ID: 12341479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in time-to-pregnancy in the USA: 2002 to 2017.
    Eisenberg ML; Thoma ME; Li S; McLain AC
    Hum Reprod; 2021 Jul; 36(8):2331-2338. PubMed ID: 34021350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced fecundity in HIV-positive women.
    Gemmill A; Bradley SEK; van der Poel S
    Hum Reprod; 2018 Jun; 33(6):1158-1166. PubMed ID: 29579247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do Knowledge and Attitudes Regarding Intrauterine Devices Predict Interest in Their Use?
    Gomez AM; Hartofelis EC; Finlayson S; Clark JB
    Womens Health Issues; 2015; 25(4):359-65. PubMed ID: 26025424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in the Use of Long-Acting Reversible Contraceptive Methods Among U.S. Nulliparous Women: Results from the 2006-2010, 2011-2013, and 2013-2015 National Survey of Family Growth.
    Ihongbe TO; Masho SW
    J Womens Health (Larchmt); 2018 Mar; 27(3):245-252. PubMed ID: 29148890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obstetrician-gynecologists and contraception: practice and opinions about the use of IUDs in nulliparous women, adolescents and other patient populations.
    Luchowski AT; Anderson BL; Power ML; Raglan GB; Espey E; Schulkin J
    Contraception; 2014 Jun; 89(6):572-7. PubMed ID: 24679477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contraceptive method use in the United States: trends and characteristics between 2008, 2012 and 2014.
    Kavanaugh ML; Jerman J
    Contraception; 2018 Jan; 97(1):14-21. PubMed ID: 29038071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrauterine devices: an effective alternative to oral hormonal contraception.
    Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.